MediWound Ltd. Issues Press Release

TL;DR

MediWound dropped a press release on 11/26, title is "Med".

AI Summary

On November 26, 2024, MediWound Ltd. announced the issuance of a press release. The press release is titled "Med". Further details regarding the content of the press release are not provided in this filing.

Why It Matters

This filing indicates that MediWound Ltd. has released new information to the public, which could contain updates on their business, financial performance, or strategic developments.

Risk Assessment

Risk Level: low — The filing is a routine report of a press release issuance and does not contain significant new financial or operational information.

Key Players & Entities

• MediWound Ltd. (company) — Registrant
• November 26, 2024 (date) — Date of press release issuance

FAQ

Filing Documents

• zk2432389.htm (6-K) — 10KB
• exhibit_99-1.htm (EX-99.1) — 413KB
• image00001.jpg (GRAPHIC) — 3KB
• 0001178913-24-003836.txt ( ) — 429KB

From the Filing

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________ FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of November 2024 Commission File Number: 001-36349 MediWound Ltd. (Translation of registrant's name into English) 42 Hayarkon Street Yavne, 8122745 Israel (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): __ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): __ EXPLANATORY NOTE On November 26, 2024, MediWound Ltd. (the "Company") issued a press release entitled "MediWound Reports Third Quarter 2024 Financial Results and Provides Company Update". A copy of this press release is attached to this Form 6-K as Exhibit 99.1. The content of this report on Form 6-K (including the information contained in Exhibit 99.1, but excluding quotes of senior management of the Company), is hereby incorporated by reference into the Company's Registration Statements on Form S-8 filed with the SEC on April 28, 2014, March 24, 2016, March 19, 2018, March 25, 2019, February 25, 2020, May 15, 2021 August 9, 2022 and August 15, 2023 (Registration Nos. No. 333-195517, 333-210375, 333-223767, 333-230487, 333-236635, 333-255784, 333-266697 and 333-273997, respectively) and on Form F-3 filed with the SEC on May 25, 2022 and August 29, 2024 (Registration Nos. 333-265203 and 333-281843, respectively). 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: November 26, 2024 MEDIWOUND LTD. By: /s/ Hani Luxenburg Name: Hani Luxenburg Title: Chief Financial Officer 3 EXHIBIT INDEX The following exhibit is filed as part of this Form 6-K: Exhibit Description 99.1 Press release dated November 26, 2024 titled "MediWound Reports Third Quarter Financial Results and Provides Company Update". 4

View Full Filing

View this 6-K filing on SEC EDGAR